Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 20, 2008 - Issue 10
121
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Effect of Moringa oleifera Lam. Seed Extract on Ovalbumin-Induced Airway Inflammation in Guinea Pigs

&
Pages 897-909 | Received 14 Oct 2007, Accepted 28 Feb 2008, Published online: 06 Oct 2008

REFERENCES

  • G. P. Anderson, and A. J. Coyle. (1994). TH2 and TH2 like cells in allergy and asthma: Pharmacological perspectives. Trends Pharmacol. Sci. 15:324–332.
  • P. J. Barnes. (1996). Pathophysiology of asthma. Br. J. Clin. Pharmacol. 42:3–10.
  • P. J. Barnes, K. F. Chung, and C. P. Page. (1998). Inflammatory mediators of asthma. Pharmacol. Rev. 50:515–596.
  • H. Bartosch, W. Feldberg, and E. Nagel. (1932). Das Freiwerden eines histaminahnlichen stoffes bei der anaphylaxie der Meerschwein chens. Pflungers. Arch. Ges. Physiol. 230:120–153.
  • C. R. Bezerra-Santos, F. M. Balestieri, B. Rossi-Bergmann,, L. M. Pecanha, and M. R. Piuvezam. (2004). Cissampelos sympodialis Eichl. (Menispermacea): Oral treatment decreases IgE levels and induces a TH1-skewed cytokine production in ovalbumin-sensitized mice. J. Ethnopharmacol. 95:191–197.
  • J. Bousquet, P. Chanez, and J. Y. Lacoste. (1990). Eosinophilic inflammation in asthma. N Engl. J. Med. 323:1033–1039.
  • J. Bousquet, P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. (2000). Asthma: From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161:1720–1745.
  • P. Bradding, J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. (1994). Interleukins-4, -5 and -6, and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol.Biol. 10:471–480.
  • D. H. Broide, and G. S. Firestein. (1991). Endobronchial allergen challenge: Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. J. Clin. Invest. 88:1048–1053.
  • D. H. Broide, M. Lotz, A. J Cuomo, D. A Coburn, E. C. Federman, and S. I. Wasserman. (1992). Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958–967.
  • A. Caceres, O. Cebreva, O. Morales, P. Miollined, and P. Mendia. (1991). Pharmacological properties of M. oleifera 1. Preliminary screening for antimicrobial activity. J. Ethnopharmacol. 33:213–216.
  • A. Caceres, A. Saravia, S. Rizzo, L. Zabala, E. De-Leon, and F. Nave. (1992). Pharmacological properties of M. oleifera 2. Screening for antispasmodic, anti-inflammatory and diuretic activity. J. Ethnopharmacol. 36:233–237.
  • R. D. Chaudhri. Herbal drug industry: A practical approach to industrial pharmacognosyR. D. Chaudhri. Eastern Publisher, New Delhi, (1996) 58–62.
  • V. C. Chitravanshi, P. P. Gupta, D. K. Kulshrestha, K. Kar, and B. N. Dhawan. (1990). Anti-allergic activity of Solanum xanthocarpum. Ind. J. Pharmacol. 22:23–24.
  • R. N. Chopra, I. C. Chopra, K. Handa, and D. Kapur. Chopra's indigenous drugs of India. Dhur, Calcutta, (1938) .
  • M. Christofidou-Solomidou, and V. R. Muzykantov. (2006). Antioxidant strategies in respiratory medicine. Treat. Respir. Med. 5:47–78.
  • K. F. Chung, and I. Adcock. Application of cell and molecular biology techniques to unravel causes and pathophysiological mechanismsAsthma mechanisms and protocolsK. F. Chungand, and I. Adcock. Humana Press, TotowaNJ, (2000) 1–29.
  • K. F. Chung, and P. J. Barnes. (1999). Cytokines in asthma. Thorax 54:825–857.
  • H. A. Cohen, K. W. Rundell, T. M. Evans, and A. M. Levine. (1997). Blocking effects of vitamin C exercise-induced asthma. Arch. Pediatr. Adolesc. Med. 151:367–370.
  • L. Cohen, and A. Ray. (2000). T-helper type-2 cell-mediated therapy for asthma. Pharmacol. Ther. 88:187–196.
  • R. K. Coker, and G. J. Laurent. (1998). Pulmonary fibrosis: Cytokines in the balance. Eur. Respir. J. 11:1218–1221.
  • M. U. Dahot, and A. R. Memon. (1985). Nutritive significance of oil extracted from Moringa oleifera seeds. J. Pharm. Univ. Karachi 3:75–80.
  • B. R. Das, P. A. Kurup, and , P. L. Narasimha Rao. (1958). Antibiotic principle from Moringa pterosperma Part IX. Inhibition of transaminase by isocyanates. Ind. J. Med. Res. 46:75–77.
  • F. M. Dayrit, A. D. Alcantara, and I. M. Villasenor. (1990). The antibiotic compound and its deactivation in aqueous solution. Phil. J. Sci. 119:23–26.
  • P. Devillier, and G. Bessard. (1997). Thromboxane A2 and related prostaglandins in airways. Fundam. Clin. Pharmacol. 11:2–18.
  • W. Duan, I. C. Kua, S. Selvarajan, K. Y. Chua, B. H. Bay, and W. S. Wong. (2003). Anti-inflammatory effects of genistein, a tyrosine kinase inhibitor, on guinea pig model of asthma. Am. J. Respir. Crit. Care Med. 167:185–192.
  • J. A. Elias, Y. Wu, T. Zheng, and R. Panettieri. (1997). Cytokine and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am. J. Physiol. 273:L648–L655.
  • S. Faizi, B. S. Siddiqui, R. Saleem, S. Siddiqui, K. Aftab, and A. H. Gilani. (1995). Fully acetylated carbamate and hypotensive thiocarbamate glycosides from Moringa oleifera. Phytochemistry (Oxford) 38:957–963.
  • M. Filipovic, and C. Snezana. (2001). The role of eosinophils in asthma. Med. Biol. 8:6–10.
  • E. Frigas, D. A. Loegering, and G .J. Gleich. (1980). Cytotoxic properties of the eosinophil major basic protein on tracheal epithelium. Lab Invest. 42:35–43.
  • M. Gharaee-Kermani, Y. Nozaki, K. Hatano, and S. H. Phan. (2001). Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokines 15:138–147.
  • A. B. Gokhale, V. J. Dikshit, A. S. Damre, K. R. Kulkarni, and M. N. Saraf. (2000). Influence of ethanolic extract of Tephrosia purpurea Linn. on mast cells and erythrocytes membrane integrity. Ind. J. Exp. Biol. 38:837–840.
  • P. Gosset, A. Tsicopoulos, B. Wallaert, C. Vannimenus, M. Joseph, A. B. Tonnel, and A. Capron. (1991). Increased secretion by tumor necrosis factor-α and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J. Allergy Clin. Immunol. 88:561–571.
  • A. P. Guevara, C. Vargas, H. Sakurai, Y. Fujiwara, K. Hashimoto, T. Maoka, M. Kozuka, Y. Ito, H. Tokuda, and H. Nishino. (1999). An antitumor promoter from Moringa oleifera Lam. Mutat. Res. 440:181–188.
  • R. H. Gundel, C. D. Wagner, and G. Letts. (1992). The onset and recovery from hyperresponsiveness: relationship with inflmmatory cell infiltrates and release of cytotoxic granule proteins. Clin. Exp. Allergy 22:303–308.
  • N. Hirata, H. Kohrogi, H. Iwagoe, E. Goto, J. Hamamoto, K. Fujii, T. Yamaguchi, O. Kawano, and M. Ando. (1998). Allergen exposure induces the expression of endothelial adhesion molecules in passively sensitized human bronchus: Time course and the role of cytokines. Am. J. Respir. Cell Mol. Biol. 18:12–20.
  • S. T. Holgate, and J. P. Finnerty. (1989). Anti-histamines in asthma. J. Allergy Clin. Immunol. 83:537–547.
  • J. M. Hughes, R. S. Stringer, J. L. Black, and C. L. Armour. (1995). The effects of tumor necrosis factor-α on mediator release from human lung. Pulmon. Pharmacol. 8:31–36.
  • K. P. Hui, I. K. Taylor, and G. W. Taylor. (1991). Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 46:184–189.
  • P. W. Ind, P. J. Barnes, M. J. Brown, R. Causen, and C. T. Dollery. (1983). Measurement of plasma histamine. Clin. Allergy 13:61–67.
  • R. Ishimitsu, H. Nishimura, H. Kawauchi, K. Kawakita, and Y. Yoshikai. (2001). Dichotomous effect of a traditional Japanese medicine, Bu-zhong-yi-qi-tang on allergic asthma in mice. Int. Immunopharmacol. 1:857–865.
  • R. V. Karadi, N. B. Gadge, K. R. Alagawadi, R. V. Savadi, V. S. Mannur, and B. C. Kotti. (2006). Anti-arthritic activity of extracts of Moringa oleifera Lam. roots. Indian Drugs 43:543–547.
  • J. C. Kips, J. Tavernier, and R. A. Pauwels. (1992). Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145:332–336.
  • K. R. Kirtikar, and B. D. Basu. Indian Medicinal Plants 2nd, D. Dun, B. Singh, and M. P. Singh. M/s Bishen Singh Mahendra Pal Singh, Dehradun, (1975) 1676–683.
  • N. Laandrault, P. Pouchert, P. Ravel, F. Gase, G. Cros, and P. L. Teissedro. (2001). Antioxidant activities phenolic level of French wines from different varieties and vintages. J. Agric. Food Chem. 49:3341–3343.
  • J. Y. Lin, M. L. Chen, B. L. Chiang, and B. F. Lin. (2006). Ganoderma tsugae supplementation alleviates bronchoalveolar inflammation in an airway sensitization and challenge mouse model. Int. Immunopharmacol. 6:241–251.
  • M. C. Liu, W. C. Hubbard, D. Proud, B. A. Stealey, S. J. Galli, A. Kagey-Sobotka, E. Bleecker, and L. M. Lichtenstein. (1991). Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: Cellular, mediator and permeability changes. Am. Rev. Respir. Dis. 144:51–58.
  • S. G. Mahajan, R. G. Mali, and A. A. Mehta. (2006). Antianaphylactic and antiinflammatory activity of hydroalcoholic extract of leaves of Moringa oleifera. Planta Indica 2:9–13.
  • S. G. Mahajan, and A. A. Mehta. (2007). Inhibitory action of ethanolic extract of seeds of Moringa oleifera Lam. on systemic and local anaphylaxis. J. Immunotoxicol. 4 (4):287–294.
  • S. G. Mahajan, R. G. Mali, and A. A. Mehta. (2007a). Protective effect of ethanolic extract of seeds of Moringa oleifera Lam. against inflammation associated with development of arthritis in rats. J. Immunotoxicol. 4:39–47.
  • S. G. Mahajan, R. G. Mali, and A. A. Mehta. (2007b). Effect of Moringa oleifera Lam. seed extract on toluene diisocyanate-induced immune-medicated inflammatory responses in rats. J. Immunotoxicol 4:85–96.
  • I. Masahiro, N. Shoji, and E. Yutaka. (2002). Effect of isolation on classical conditioned histamine release in guinea pigs. Neurosci. Res. 44:31–35.
  • G. M. Memon, and L. M. Khatri. (1987). Isolation and spectroscopic studies of mono-palmitic, di-oleic triglyceride from seeds of Moringa oleifera Lam. Pak. J. Sci. Ind. Res. 30:393–395.
  • G. M. Memon, S. A. Memon, and A. R. Memon. (1985). Isolation and structure elucidation of moringyne, a new glycoside from the seeds of M. oleifera. Pak. J. Sci. Ind. Res. 28:7–9.
  • L. Michael, and K. Horst. (1998). Synthesis of active principles from the leaves of Moringa oleifera using S-pent-4-enyl thioglycosides. Carbohydr. Res. 312:33–44.
  • S. Motojima, E. Frigas, D. A. Loegering, and G. J. Gleich. (1989). Toxicity of eosinophil cationic proteins for guinea-pig tracheal epithelium in vitro. Am. Rev. Respir. Dis. 139:801–805.
  • M. H. Mughal, G. Ali, P. S. Srivastava, and M. Iqbal. (1999). Improvement of drumstick (Moringa pterygosperms Gaertn.) a unique source of food and medicine through tissue culture. Hamdard Med. 42:37–42.
  • Indian materia medica. K. M. Nadkarni, and A. K. Nadkarni. Popular Prakashan, Mumbai, (1976) 1811–816.
  • A. M. Nair, and M. N. Saraf. (1995). Inhibition of antigen and compound 48/80 induced contractions of guinea pig trachea by the ethanolic extract of the leaves of Vitex negundo Linn. Ind. J. Pharmacol. 27:230–233.
  • S. Nayampalli, N. K. Desai, and S. S. Ainapure. (1986). Anti-allergic properties of Tinospora cordifolia in animal models. Ind. J. Pharmacol. 18:250–252.
  • O. U. Njoku, and M. U. Adikwu. (1997). Investigation on some physicochemical antioxidant and toxicological properties of Moringa oleifera seed oil. Acta Pharm. Zagr. 47:287–290.
  • P. O. Ogunbiyi, and P Eyre. (1985). Pharmacological studies of pulmonary anaphylaxis in vitro. Agents Action 17:158–173.
  • Y. Ohkawara, K. Yamauchi, Y. Tanno, H. Tamura, H. Outani, H. Nagura, K. Ohkuda, and T. Takishima. (1992). Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering. Am. J. Respir. Cell Mol. Biol. 7:385–392.
  • I. Ohno, Y. Ohkawara, K. Yamauchi, Y. Tanno, and T. Takishima. (1990). Production of tumour necrosis factor with IgE receptor triggering from sensitized lung tissue. Am. J. Respir. Cell Mol. Biol. 3:285–289.
  • C. L. Ordonez, T. E. Shaughnessy, M. A. Matthay, and J. V. Fahy. (2000). Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. Am. J. Respir Crit. Care. Med. 161:1185–1190.
  • Modern methods of plant analysis. D. Paech, and M. V. Tracey. Springer-Verlag, Berlin, (1955) IV373–374.
  • M. Pretolani, C. Ruffie, D. Joseph, M. G. Campos, M. K. Church, J. Lefort, and B. Vargaftig. (1994). Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am. J. Respir. Crit. Care Med. 149:1167–1174.
  • D. G. Raible, T. Lenahan, Y. Fayvilevich, R. Kosinski, and E. S. Schulman. (1994). Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am. J. Respir. Crit. Care Med. 149:1506–1511.
  • B. K. Rajan. (1986). Apiculture and farm forestry in semi-acid tracts of Karnataka. My For. 22:41–49.
  • M. Ricci, A. Matucci, and O. Rossi. (1994). Recent advances in the pathogenetic mechanisms and genetic aspects of atopic diseases. Allergy. Clin. Immunol. News. 6:103–108.
  • D. S. Robinson, Q. Hamid, Y. Sun, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. (1992). Predominant TH2-1ike bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298–304.
  • A. Saria, M. J. Lundberg, G. Skoftsch, and F. Lembeck. (1983). Vascular protein leakage in various tissues is induced by substance P, capsaicin, bradykinin, serotonin, histamine, and by antigen challenge. Arch. Pharmacol. 324:212–218.
  • R. Sergio. (2000). The role of lymphocytes in allergic diseases. J. Allergy Clin. Immunol. 105:399–408.
  • P. A. Shore, A. Burkhalter, and V. H. Cohn. (1959). A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127:182–186.
  • R. K Singh, S. K. Bhattacharya, and S. B. Acharya. (2000). Studies on extracts of Elaeocarpus sphaericus fruits on in vitro rat mast cells. Phytomedicine 7:205–207.
  • S. Sur, T. B. Crotty, and G. M. Kephart. (1993). Sudden onset fatal asthma: A distinct clinical entity with few eosinophils and relatively more neutrophils in the airway submucosa?. Am. Rev. Respir. Dis. 148:713–719.
  • T. C. Theoharidesa, and D. E. Cochraned. (2004). Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146:1–12.
  • R. M. Tripathi, and P. K. Das. (1977). Studies on anti-asthmatic and anti-anaphylactic activity of Albizzia lebbeck. Ind. J. Pharmacol. 9:189–194.
  • V. P. Varier. Indian medicinal plants compendium of 500 speciesP. K. Warrier, V. P. Nambiar, and C. Ramankutty. Orient Longman, Madras, (1997) 458–62.
  • I. M. Villasenor. (1994). Bioactive metabolites from Moringa oleifera Lam. Kimika 110:47–52.
  • I. M. Villasenor, F. Dayrit, and C. Y. Lim-Sylianco. (1990). Studies on M. oleifera seeds, Part II. Thermal degradation of roasted seeds. Phil. J. Sci. 119:33–39.
  • I. M. Villasenor, C. Y. Lim-Sylianco, and F. Dayrit. (1989). Mutagens from roasted seeds of Moringa oleifera. Mutat. Res. 224:209–212.
  • A. J. Wardlaw, S. Dunnette, G. J. Gleich, J. V. Collins, and A. B. Kay. (1988). Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62–69.
  • S. E. Wenzel, S. J. Szefler, and D. Y. Leung. (1997). Bronchoscopic evaluation of severe asthma. Am. J. Respir Crit. Care Med. 156:737–743.
  • S. Ying, M. Humbert, J. Barkans, C. J. Corrigan, R. Pfister, G. Menz, M. Larche, D. S. Robinson, S. R. Durham, and A. B. Kay. (1997). Expression of IL-4 and IL-5 mRNA and protein product by CD41 and CD81 T-cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158:3539–3544.
  • I. Ziment. (1997a). Alternative therapies for asthma. Curr. Opin. Pulmon. Med. 3:61–71.
  • I. Ziment. Alternative therapiesAsthmaP. J. Barnes, M. M. Grunstein, A. R. Leff, and A. J. Woolcock. Lippincott-Raven, Philadelphia, (1997b) 1689–1705.
  • I. Ziment, and D. P. Tashkin. (2000). Alternative medicine for allergy and asthma. J. Allergy Clin. Immunol. 106:603–614.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.